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 In the short term, acute kidney injury 
(AKI) leads to death. Population-based 
studies have identifi ed in-hospital case-
fatality rates for AKI, variously defi ned, 
ranging between 45 % and 70 % . 1 In 2005, 
Chertow  et al. analyzed data from nearly 
20,000 consecutive admissions to an 
urban medical center and found that an 
increase of creatinine as small as 0.3  mg / dl 
conferred a 70 % increase in adjusted odds 
of death. 2 Th e RIFLE criteria, fi rst intro-
duced as a means to  standardize defi ni-
tions of AKI and target research and care, 
have become a risk stratifi cation tool for 
in-hospital mortality. With increasing 
degrees of renal  dysfunction, regardless of 
renal outcome,  mortality increases in a 
graded and  faithful manner. 3 
 Th e epidemiologic link is solid between 
AKI and short-term morbidity and mor-
tality. Long-term implications of an epi-
sode of AKI have been less well explored. 
Early studies estimating long-term risk 
aft er an episode of AKI consisted of small 
prospective observational studies of inci-
dent patients with AKI. Th ey consistently 
found a decrease in glomerular fi ltration 
rate (GFR) months after the initial 
insult, 4,5 even with full restoration of renal 
blood fl ow. Th e reduction in GFR was sel-
dom less than 50  cc / min from baselines of 
about 100  ml / min and was therefore 
ignored, and the eff ect on long-term mor-
tality was frequently underestimated. 
Residual chronic kidney disease (CKD) 
was attributed to obliteration of nephrons 
with the AKI episode. 6 Other early histo-
logic changes included vascular denuda-
tion, patchy scarring, and dilated tubules 
with fl attened epithelium. 4 Th e consistent 
long-term decrease in  creatinine clearance 
does argue for a structural lesion  involving 
the nephrons in all cases ( Figure 1 ). 
 Recent epidemiology reveals that an epi-
sode of AKI, regardless of recovery and 
extent of recovery, unequivocally leads to 
increased mortality and increased CKD, in 
the long term. 1,7,8 Th e more severe the epi-
sode of AKI, the more robust is this cor-
relation. The etiology of AKI and its 
duration do not seem to contribute to this 
correlation. 1,7 While mild AKI is associated 
with a 70 % increase in mortality risk, the 
risk of long-term death was nearly three-
fold greater in patients with mild to moder-
ate AKI as compared with their non-AKI 
counterparts. 7 In an attempt to survey the 
chronic consequences of AKI, the National 
Institute of Diabetes and Digestive and 
Kidney Diseases has funded a prospective 
study composed of a consortium of several 
institutions, AKI-ASSESS . Th e results of 
their work are several years away. 
 Although critiques of the causal role of 
AKI in short- and long-term mortality 
argue that those patients who get AKI are 
simply sicker, there is enough evidence to 
suggest that, independent of confounding 
variables, AKI causes some bad outcomes. 
Th e pathophysiology of AKI and its eff ects 
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 Most epidemiologic data, thus far, have focused on short-term 
outcomes of acute kidney injury (AKI). Lo  et al. correlate AKI with 
long-term outcomes. The concept of   ‘ uremic memory ’ sheds light on 
the importance of AKI and its permanent imprint. The focus of research 
should be on prevention of an episode of AKI, when possible. 
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on remote organs are topics of great inter-
est that have been most extensively 
researched in animal models. Chemical 
mediators (such as cytokines, comple-
ment, chemokines, and oxygen free radi-
cals) play a large role in the infl ammatory 
response of AKI. 9 Ischemia and hypoxia 
as direct insults to the tubulointerstitial 
cells initiate transcription of proinfl am-
matory cytokines (such as interleukin-1, 
interleukin-6, and tumor necrosis 
factor-  ). 9 Th ese mediate the cascade of 
infl ammatory reactions , furthering injury 
during the reperfusion phase. Th ese sys-
temic events aff ect distant organs as well. 
Cardiac alterations, abnormal lung physi-
ology, and endothelial dysfunction have 
all been implicated during AKI. 9 
 Animal studies examining long-term 
eff ects of AKI have demonstrated struc-
tural and functional residua to experimen-
tal AKI. In a rat model, an episode of 
ischemia / reperfusion (I / R) was shown to 
have long-term eff ects on renal function 
despite complete clinical recovery. 10,11 
Morphologic studies showed that impaired 
function was associated with widespread 
tubulointerstitial disease. Some tubules 
were atrophic and others dilated. Th e inter-
stitial volume fractions were increased. 
Furthermore, while many glomeruli 
retained open capillary loops aft er injury, 
they were disconnected from their respec-
tive tubules aft er I / R injury. 10 In fact, GFR 
was closely related to the number of 
glomeruli that remained connected to nor-
mal tubules. In addition, single-nephron 
GFR values returned to normal aft er I / R, 
but there was complete loss of function in 
a large portion of the nephrons. 10 Mouse 
models show vascular rarefaction, 
increased interstitial fi brosis, and dilated 
tubules long after one episode of I / R, 
despite complete clinical recovery. 11 
 Lo  et al. 12 (this issue) now rigorously 
examine the long-term sequelae of AKI. 
Th eirs is a retrospective analysis of the 
large Kaiser Permanente database using 
the years 1996 – 2003. Th ey explore AKI 
and its correlation with long-term kidney 
disease and mortality in comparison with 
enrollees of the same health-care organi-
zation who did not develop AKI and thus 
served as controls. Th eir study focuses on 
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treatment became available, this residue of 
damage might persist with chronic decay 
in renal function. Prevention would seem 
a very important focus of AKI research. 
Aft er all, much AKI occurs as a result of 
what happens to a patient once in the 
medical system and, if not strictly iatro-
genic, is at least potentially avoidable or 
mitigable. Perhaps we should risk-stratify 
all patients who are hospitalized for AKI 
risk, or at least those who are expected to 
undergo certain procedures. We need to 
devise methods by which we can prevent 
AKI in the setting of a known renal insult, 
such as contrast, cardiopulmonary bypass, 
vascular intervention, or nephrotoxic 
medication. Any degree of prevention is 
worthy of consideration, as even subtle 
derangements in the kidney can have both 
short- and long-term  consequences. 
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patients with estimated GFRs greater than 
45  cc / min / 1.73  m 2 at baseline. As com-
pared with controls, patients who suff ered 
dialysis-dependent AKI during their hos-
pitalization had a 28-fold increased risk of 
developing stage 4 CKD or end-stage renal 
disease. Th ere was also a more than two-
fold risk of long-term death in this group. 
Although the major diff erences between 
cohorts in their baseline characteristics is 
a source of bias, at the very least, AKI 
serves as an easily assessable prognostic 
marker for long-term CKD and long-term 
morality. Matching of the cohorts was 
used to reduce some of this bias, as were 
multivariate and sensitivity analyses. Th us 
the internal validity of AKI and its causal 
role in CKD and  mortality, within the lim-
its of statistical ability, is established. 
 The distinction between structural 
(parenchymal) renal damage and func-
tional renal disease during an episode of 
AKI is practically impossible. Serum 
markers such as urea and creatinine are 
incapable of making this distinction, and 
newer urinary biomarkers have so far 
fallen short of doing so. At what point 
does decreased renal perfusion, which 
implies vascular pathology only, with an 
element of reversibility, become irrevers-
ible and definitive in its parenchymal 
insult to the tubules? Certainly one would 
expect that the greater the degree of dam-
age to the parenchyma of the kidney, the 
worse the consequences. Perhaps the dra-
matic surge of mediators and immune 
factors occurs in response to any altera-
tion in the normal kidney milieu. The 
kidney, because of its intense metabolic 
and oxygen requirements, is particularly 
sensitive, and by the time an increase in 
creatinine (still the gold-standard marker 
for any of the new defi nitions) occurs, a 
great deal of damage with long-term con-
sequences has occurred. 
 An episode of hyperglycemia causes dra-
matic changes in gene expression of nuclear 
factor-  B, monocyte chemoattractant pro-
tein, and vascular adhesion molecules. 13 
Th is eff ect, known as hyperglycemic mem-
ory, highlights the dramatic and long-last-
ing eff ects that short-term hyperglycemic 
spikes may have on vascular beds and sug-
gests a mechanism for long-term sequelae. 
We believe an analogous model might 
explain the long-term eff ects of an episode 
of AKI.  ‘ Uremic memory ’ consists of per-
manent  pathologic changes visited on the 
kidney with an episode of AKI. Interstitial 
fi brosis,  vascular denudation and degrada-
tion, atubular glomeruli, and a higher 
 interstitial-to-glomerular ratio are some 
histologic imprints of a past episode of 
AKI. 10,11 Th e upsurge of profi brotic and 
apoptotic factors aft er an acute episode of 
infl ammation and the eff ects on remote 
organs is further evidence to support the 
concept of uremic memory. 9 
 AKI causes CKD and death in both the 
short and the long term. Uremic memory 
enables one episode of AKI, regardless of 
complete recovery, to leave an imprint in 
a patient, putting him or her at risk for 
long-term morbidity and mortality. Treat-
ments to hasten recovery of established 
AKI remain elusive, but even if such a 
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 Figure 1  |  Epidemiologic associations between causes and consequences of acute kidney 
injury and potential areas where physicians can effect change in these associations. 
